BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• FDA

  Abbott Laboratories Receives European CE Mark Approval for FreeStyle Navigator(R) Continuous Glucose Monitoring System

  June 6, 2007

   · 

  6 min read
• Genetown

  Tepha, Inc. Announces $10.7 Million Venture Capital Financing

  June 6, 2007

   · 

  2 min read
• AstraZeneca PLC (Jobs) Finance Chief Quits to Join Goldman, Sachs & Co.

  June 6, 2007

   · 

  1 min read
• FDA

  InSightec Receives European CE Mark for ExAblate(R) 2000 Treatment of Pain Caused by Bone Metastases

  June 6, 2007

   · 

  2 min read
• Drug Development

  Surface Logix Starts Phase 2a Clinical Trial of SLx-4090 in Dyslipidemia

  June 6, 2007

   · 

  3 min read
• Drug Development

  ROXRO PHARMA Inc.'s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study

  June 6, 2007

   · 

  2 min read
• Drug Development

  MAP Pharmaceuticals, Inc. to Present MAP0004 Phase 2 Clinical Data at the American Headache Society Meeting

  June 6, 2007

   · 

  2 min read
• Drug Development

  Anacor Pharmaceuticals, Inc. Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis

  June 6, 2007

   · 

  2 min read
• Pharm Country

  Amazon Biotech Announces Symbol Change to “AMZO”

  June 6, 2007

   · 

  1 min read
• Drug Development

  PRANA Biotechnology Presents New Key Findings on PBT2

  June 6, 2007

   · 

  1 min read